Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing medicines consisting of therapeutics paired with companion diagnostics for the treatment of cancer. Its therapeutic oncology candidates in clinical development include MM-398, MM-302, MM-121, MM-141 and MM-151. Its ONIVYDE (irinotecan liposome injection), also known as MM-398, is an encapsulation of the marketed chemotherapy drug irinotecan in a liposomal formulation. MM-302 is an antibody drug conjugated liposomal doxorubicin that targets the ErbB2 (HER2) receptor. MM-121 is a fully human monoclonal antibody that targets Erb-B2 Receptor Tyrosine Kinase 3 (ErbB3). MM-141 is a fully human tetravalent bispecific antibody designed to block tumor survival signals by targeting receptor complexes. MM-151 is an oligoclonal therapeutic designed to bind to non-overlapping epitopes of EGFR (ErbB1)
They are attending the ASCO this weekend in the Bay Area, plus they are in Phase 1study of colorectal cancer drug. I have a small position 1k shs in this name nice to see Brendan aka binky if I remember correctly from the old days on this. @Gil he's not pulling a bigmike lol.
Nope I just go into Stockcharts and look at stocks I put in there previously. Sometimes I just look at ones I traded before for fun I generally trade the same 30-40 stocks over and over
I find that after a while of following a stock, you get a feel for how it trades, which is what I see you doing a lot.
Totally agree on that. When trading stocks I am familiar with some times I know what is a good buying op without even looking at the charts. I usually know when a sell off is overdone and act accordingly. I trade most of my stocks over and over again until they stop performing for me. I think I am on trade #8 on WPX per example.
I am not bullish for the week or month, but for the next year at least. This week looks a little bearish until Friday maybe longer.
Merrimack Pharma Rises on Positive Late-Stage Results http://finance.yahoo.com/news/merrimack-pharma-rises-positive-stage-131505392.html
$MACK volume will reach record highs today. Under $4 easy. Going to $3, at which point I will close my short position
Merrimack Pharma (MACK) to Divest Assets in Deal Valued at $1.03B Source: http://www.streetinsider.com/Corpor...Assets+in+Deal+Valued+at+$1.03B/12405549.html Gapped up today but giving back almost all of those gains. Still up over 8% though.
